HTG Molecular Diagnostics to Present at H.C. Wainwright’s 23rd Annual Global Investment Conference

TUCSON, Ariz., Sept. 08, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that company management will participate in H.C. Wainwright’s 23rd Annual Global Investment Conference, being held September 13th – 15th, 2021.

Details for the presentation are below:

Date:7:00 a.m. ET
Time:Monday, September 13th, 2021
Webcast:https://journey.ct.events/view/36113800-95ac-4c91-b29a-d6ec60e0fddf

Management will also be available for 1x1 meetings. If you would like to request a meeting, please email meetings@hcwco.com.

About HTG:
HTG is focused on NGS-based molecular profiling. The company’s proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. Its mission is to empower precision medicine. To learn more, visit www.htgmolecular.com.

Contact:

Ashley Robinson
Phone: (617) 430-7577
Email: arr@lifesciadvisors.com 


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.